Plant Advanced Technologies PAT: management transactions · France · AMF

About Plant Advanced Technologies PAT

Plant Advanced Technologies PAT is a French plant-biotechnology company listed on Euronext Growth Paris under ISIN FR0010785790 (ticker ALPAT). Founded in June 2005 in Nancy, the company was originally created to develop and industrialize the PAT plantes à traire® technology, which was built on research from the Institut National Polytechnique de Lorraine and INRA. Since then, PAT has established itself in a highly specialized niche focused on the discovery, optimization and industrial production of rare plant biomolecules that have traditionally been difficult to source at scale. PAT’s core business is the development of plant-derived active ingredients for the cosmetics, pharmaceutical and agrochemical industries, with an expanding presence in nutraceuticals and fine chemicals. The group emphasizes exclusive, high-value solutions that combine innovation, traceability and control over the full value chain, from the plant to the final product. Its technological platform includes proprietary approaches such as PAT plantes à traire® and PAT Friday®, as well as metabolic engineering and microbial fermentation through its Cellengo subsidiary. Over time, PAT has built a diversified scientific and industrial platform. In cosmetics, it regularly launches new active ingredients and works with industrial partners. In pharmaceuticals, its Temisis subsidiary is focused on small molecules with notable anti-inflammatory potential. In agrochemistry, PAT develops and tests molecules for crop protection. The group also owns StratiCell, which provides cosmetic efficacy and safety testing, and Couleurs de Plantes, which specializes in plant-based colorants. These assets broaden PAT’s commercial reach while leveraging the same underlying scientific expertise. From a market positioning standpoint, PAT is best described as an innovation-driven niche specialist rather than a large-scale industrial supplier. Its competitive strength lies in scarce active ingredients, a sizeable intellectual-property portfolio, and a strong scientific workforce of more than 60 employees, roughly two-thirds of whom are dedicated to R&D. The company also highlights its sustainability credentials, including a 2024 EcoVadis Gold medal. Financially, PAT reached an important milestone in 2024 by posting its first operating profit since inception, at €215k, on revenue of €1.927 million. In the first half of 2025, revenue stood at €155k in a seasonal business context, while debt continued to decline and management reiterated its goal of generating a third consecutive full-year profit. Headquartered in Vandœuvre-lès-Nancy, the group maintains an operational and partnership footprint in France and Belgium, while targeting international markets through collaborations and patented technologies.